Clinical Trial Update: A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating mRNA-4106 alone and in combination with immune checkpoint blockade in participants with solid tumors; the study is active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• mRNA-4106

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Advanced Solid Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING